Combination therapy in phase 2 development. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy2

Cell Line, Tumor Tumor Cells, Cultured

Organisms9

Plasmodium falciparum Mice, Nude Hepacivirus Mice, SCID Mice, Inbred BALB C Hepatitis B virus HIV-1 Plasmodium Mice, Inbred C57BL

Diseases29

Malaria, Falciparum Hepatitis C, Chronic Malaria Parasitemia Hepatitis B, Chronic Disease Progression Disease Models, Animal Recurrence Arthritis, Rheumatoid Hypertension HIV Infections Neoplasms Neutropenia Lung Neoplasms Neoplasm Metastasis Invasive Pulmonary Aspergillosis Mucormycosis Liver Neoplasms Breast Neoplasms Neovascularization, Pathologic Fever Diabetes Mellitus, Type 2 Hepatitis C Ovarian Neoplasms Aspergillosis Pancreatic Neoplasms Prostatic Neoplasms Neoplasms, Experimental Multiple Myeloma

Chemicals and Drugs147

Artemisinins Drug Combinations Antimalarials Ribavirin Fluorenes Antiviral Agents Interferon-alpha Ethanolamines Amodiaquine Mefloquine Polyethylene Glycols Sulfadoxine Sesquiterpenes Pyrimethamine Antineoplastic Agents Antihypertensive Agents Sulfasalazine Chloroquine Lamivudine Organophosphonates Hydrochlorothiazide Deoxycytidine Amlodipine Antibodies, Monoclonal Tetrazoles Antirheumatic Agents Methotrexate Anti-Bacterial Agents Pyrazines Recombinant Proteins Oxonic Acid Quinolines Angiotensin-Converting Enzyme Inhibitors Echinocandins Angiotensin II Type 1 Receptor Blockers Adenine Antibodies, Monoclonal, Humanized Didanosine Antifungal Agents Anti-HIV Agents Azetidines Paclitaxel Triazoles Nifurtimox Reverse Transcriptase Inhibitors Boronic Acids Angiogenesis Inhibitors Fluorouracil Zidovudine Fenofibrate Amphotericin B Hydroxychloroquine Tegafur Taxoids Antimetabolites, Antineoplastic Cisplatin Bronchodilator Agents Adrenal Cortex Hormones Hypoglycemic Agents Albuterol Benzimidazoles Pyrimidines Benzenesulfonates Metformin Immunosuppressive Agents Prednisolone Niacinamide Phenylurea Compounds Diuretics Simvastatin Sulfonamides Piperazines Antineoplastic Agents, Phytogenic Pyrroles Anti-Asthmatic Agents Indoles Hypolipidemic Agents Immunologic Factors Hydroxymethylglutaryl-CoA Reductase Inhibitors Glucocorticoids Lisinopril Doxorubicin Cyclophosphamide Aminoglycosides RNA, Viral Thalidomide Adrenergic beta-2 Receptor Agonists Niacin Anticholesteremic Agents Interferons Sirolimus Purines Quinine Valine Calcium Channel Blockers Camptothecin Angiotensin Receptor Antagonists Sulfones Chlorobenzenes Pyridines Fumarates Protein Kinase Inhibitors Alanine Transaminase Quinazolines Lactones Rifampin Indinavir Dipeptidyl-Peptidase IV Inhibitors Pyridones Sulfonylurea Compounds Adrenergic beta-Agonists Benzamides Anti-Inflammatory Agents 2-Aminopurine Valproic Acid Flucytosine Zalcitabine Thiazolidinediones Platelet Aggregation Inhibitors Anti-Infective Agents Hydroxamic Acids Azetidinecarboxylic Acid Cyclosporine Histone Deacetylase Inhibitors Guanine HIV Protease Inhibitors Colistin Adamantane Imidazoles Lipopeptides Losartan Aspirin Paromomycin Heptanoic Acids Doxazosin Antiprotozoal Agents Biphenyl Compounds Antibiotics, Antineoplastic Thiazepines Phosphodiesterase 5 Inhibitors Clarithromycin Minocycline Scopolamine Derivatives Hepatitis B e Antigens Androstadienes Antibodies, Monoclonal, Murine-Derived Fluconazole

Analytical, Diagnostic and Therapeutic Techniques and Equipment41

Drug Therapy, Combination Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Drug Administration Schedule Xenograft Model Antitumor Assays Administration, Oral Double-Blind Method Clinical Trials as Topic Randomized Controlled Trials as Topic Retrospective Studies Treatment Failure Parasitic Sensitivity Tests Disease Models, Animal Administration, Inhalation Viral Load Prospective Studies Survival Analysis Follow-Up Studies Drug Evaluation, Preclinical Neoplasm Transplantation Microbial Sensitivity Tests Tumor Burden Immunotherapy Inhibitory Concentration 50 Infusions, Intravenous Blood Pressure Severity of Illness Index Survival Rate Molecular Targeted Therapy Parasite Load Drug Screening Assays, Antitumor Pulse Therapy, Drug Cross-Over Studies Disease-Free Survival Remission Induction Oncolytic Virotherapy Area Under Curve Neoplasms, Experimental Genetic Therapy Cohort Studies

Phenomena and Processes19

Drug Synergism Drug Resistance Dose-Response Relationship, Drug Drug Interactions Time Factors Apoptosis Drug Resistance, Neoplasm Viral Load Cell Proliferation Drug Resistance, Viral Drug Resistance, Multiple Genotype Inhibitory Concentration 50 Drug Resistance, Microbial Blood Pressure Cell Survival Signal Transduction Mutation Area Under Curve

Technology, Industry, Agriculture1

Polyethylene Glycols

Information Science1

Health Care19

Treatment Outcome Double-Blind Method Clinical Trials as Topic Randomized Controlled Trials as Topic Retrospective Studies Treatment Failure Prospective Studies Survival Analysis Follow-Up Studies Pharmacies Drug Costs Cost-Benefit Analysis Severity of Illness Index Survival Rate Cross-Over Studies Disease-Free Survival Practice Guidelines as Topic Area Under Curve Cohort Studies

Geographicals6

Tanzania Cambodia Senegal Uganda Africa Thailand

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Technology, Industry, Agriculture Information Science Health Care Geographicals

Drug Therapy, Combination Artemisinins Drug Combinations Antimalarials Treatment Outcome Ribavirin Fluorenes Drug Synergism Antiviral Agents Interferon-alpha Ethanolamines Antineoplastic Combined Chemotherapy Protocols Amodiaquine Malaria, Falciparum Combined Modality Therapy Hepatitis C, Chronic Mefloquine Drug Administration Schedule Polyethylene Glycols Sulfadoxine Sesquiterpenes Pyrimethamine Malaria Drug Resistance Antineoplastic Agents Antihypertensive Agents Sulfasalazine Xenograft Model Antitumor Assays Chloroquine Cell Line, Tumor Plasmodium falciparum Lamivudine Organophosphonates Dose-Response Relationship, Drug Hydrochlorothiazide Deoxycytidine Amlodipine Drug Interactions Antibodies, Monoclonal Administration, Oral Tetrazoles Double-Blind Method Antirheumatic Agents Time Factors Methotrexate Mice, Nude Anti-Bacterial Agents Pyrazines Recombinant Proteins Clinical Trials as Topic Oxonic Acid Quinolines Angiotensin-Converting Enzyme Inhibitors Parasitemia Echinocandins Angiotensin II Type 1 Receptor Blockers Tanzania Adenine Antibodies, Monoclonal, Humanized Apoptosis Didanosine Drug Resistance, Neoplasm Antifungal Agents Anti-HIV Agents Azetidines Paclitaxel Triazoles Nifurtimox Reverse Transcriptase Inhibitors Boronic Acids Angiogenesis Inhibitors Randomized Controlled Trials as Topic Fluorouracil Retrospective Studies Zidovudine Fenofibrate Amphotericin B Hepacivirus Hepatitis B, Chronic Hydroxychloroquine Tegafur Disease Progression Treatment Failure Parasitic Sensitivity Tests Taxoids Disease Models, Animal Antimetabolites, Antineoplastic Cisplatin Bronchodilator Agents Adrenal Cortex Hormones Hypoglycemic Agents Recurrence Albuterol Benzimidazoles Cambodia Administration, Inhalation Pyrimidines Benzenesulfonates Viral Load Metformin

No FAQ available that match "combination therapy in phase 2 development"